Michael Vasconcelles

Michael J.
Vasconcelles currently serves as Independent Non-Executive Director at Molecular Partners AG since 2020, Director at Molecular Partners, Inc., Independent Director at Kura Oncology, Inc. since 2024, Senior Advisor at Frazier Management LLC since 2019, Head-Research & Development at Day One Biopharmaceuticals, Inc. starting 2025, and is a Member of both the American Society of Clinical Oncology, Inc. and the American Society of Hematology.
Former roles include Director at American Cancer Society, New England Division, Inc., Independent Director at Magenta Therapeutics, Inc., Director at Personalized Medicine Coalition, Chief Medical Officer at Cogent Biosciences, Inc. from 2015 to 2019, Executive VP-Research & Medical Affairs at ImmunoGen, Inc. from 2023 to 2024, Faculty Member at Harvard Medical School from 1996 to 2021, Chief Medical Officer at Flatiron Health, Inc. from 2019 to 2022, Senior VP & Head-Oncology Therapy Area Unit at Takeda Pharmaceuticals International, Inc. from 2012 to 2015, Global Therapeutic Area Head-Transplant & Oncology at Sanofi, Group VP & Head-Global Therapeutic Area at Genzyme Corp.
from 2000 to 2011, and Head-Personalized Medicine & Companion Diagnostics at Sanofi Oncology from 2011 to 2012.
Education includes undergraduate studies at Northwestern University and a doctorate from Feinberg School of Medicine.